"Don't trust your skin to just anyone. Skin (Dermatology) is our specialty, our medical professionals are among the best in the business. Our goal is to always deliver quality services and products at an affordable price. We want you, our valued customer, to be happy. Remember 'When you look good, we look good'."

During the past decade, Dermatology and Advanced Aesthetics conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology and Advanced Aesthetics" #1 sponsor was "Amgen" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Encore Dermatology, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology and Advanced Aesthetics" #1 collaborator was "Prosoft Clinical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology and Advanced Aesthetics" are "Psoriasis" (7 trials), "Plaque Psoriasis" (3 trials), "Atopic Dermatitis" (1 trials), "Cutaneous Lupus Erythematosus" (1 trials) and "Plaque-type Psoriasis" (1 trials). Many other conditions were trialed in "Dermatology and Advanced Aesthetics" in a lesser frequency.

Most popular intervention types in "Dermatology and Advanced Aesthetics" are "Drug" (11 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apremilast" (3 trials), "BMS-986165" (2 trials), "Apremilast 10mg" (1 trials) and "Apremilast 20mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology and Advanced Aesthetics" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology and Advanced Aesthetics". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Dermatology and Advanced Aesthetics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology and Advanced Aesthetics, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".